Chargement en cours...
Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux(® )and particle therapy]
BACKGROUND: Local control in adjuvant/definitive RT of adenoid cystic carcinoma (ACC) is largely dose-dependent leading to the establishment of particle therapy in this indication. However, even modern techniques leave space for improvement of local control by intensification of local treatment. Rad...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3042975/ https://ncbi.nlm.nih.gov/pubmed/21320355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-70 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|